Will the competition between Levemir·Victoza and Lantus·Lyxumia get severe?
As the beneficiary standard for diabetes has been changed since the 1st, basal insulins have been reevaluated. It seems that prescriptions of insulins will increase due to the changed beneficiary standard and recognition of joint benefits with DDP-4 inhibitors.
So far, even though a medical prov...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
